Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. financial statements

Brainstorm Cell Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 703KEODHD
Net income−USD 10.31M10-K
Cash and equivalentsUSD 29K10-Q
Total debtUSD 208KEODHD

Brainstorm Cell Therapeutics Inc. financials on 6ix · Brainstorm Cell Therapeutics Inc. on 6ix